Outset Medical, Inc.

OM Healthcare Medical Devices

Outset Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $119.5 million, up 5.09% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 6.73%, free cash flow fell 90.5% and total debt rose 4.20%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

3.94 0.14 −3.43%
Market cap
$76.6M
P/E
0.0×
Fwd P/E
−1.1×
Dividend yield
—
F-score
6/9
Altman Z
−5.37
Beneish M
−3.25
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18
Cash and Short Term Investments
168.95 158.69 203.32 287.50 339.49 314.87 70.08 142.78
Receivables
28.33 35.62 32.98 28.07 25.60 6.47 3.91 1.09
Inventory
47.61 59.39 49.22 51.48 39.19 18.38 4.60 3.02
Total current assets
250.88 258.22 291.22 373.65 409.80 345.91 79.65 147.65
Property, Plant, Equpment (Net)
4.67 8.13 13.27 15.88 12.96 15.00 7.90 2.93
Goodwill and Intangible Assets (Total)
— — — — — — — 0.00
Long-term assets (Other)
4.15 5.50 3.93 4.48 33.47 34.67 0.83 0.41
Total non-current assets
13.61 17.57 22.58 26.47 53.66 57.92 8.72 —
Total Assets
264.50 275.80 313.80 400.12 463.46 403.83 88.37 —
Accounts Payable
0.55 3.86 5.83 0.60 1.76 4.95 4.96 3.37
Accrued Expenses
21.54 26.96 36.18 41.37 42.44 27.66 11.57 —
Current Part of Debt
— — — — — — 7.50 0.52
Current Part of Capital Lease
— — — — — — — 0.00
Current Part of Taxes to Pay
— — — — — — — 0.00
Current Revenue (Deferred)
13.80 12.75 11.73 8.66 6.34 3.20 0.88 —
Total current liabilities
37.63 45.38 55.32 51.95 51.70 36.69 24.91 10.21
Long Term Debt (Total)
96.24 197.38 130.11 96.34 29.76 29.67 21.56 28.36
Non-current Revenue (Deferred)
0.41 0.84 0.10 0.15 0.31 0.57 0.13 0.00
Preferred Shares of Subsidiary (Mandatory, Redeemable)
— — — — — — 4.29 —
Minority Interests
— — — — — — — 0.00
Non-current Liabilities (Other)
— 2.70 0.90 0.11 0.72 0.24 0.22 8.22
Total non-current liabilities
99.91 203.60 135.59 102.18 37.69 38.53 26.20 —
Total liabilities
137.54 248.98 190.92 154.13 89.38 75.22 51.11 —
Additional Paid In Capital
1,298.14 1,116.50 1,084.52 1,035.46 1,000.21 822.62 0.36 0.00
Preferred Stock (Total)
— — — — — — 409.45 0.00
Common Stock (Net)
0.02 0.00 0.05 0.05 0.05 0.04 0.00 0.00
Retained Earnings
(1,171.38) (1,089.72) (961.75) (788.95) (625.99) (494.06) (372.57) (287.90)
Treasury Stock
— — — — — — — 0.00
Shareholders Equity (Other)
— — — — — — — 0.00
Common Equity (Total)
126.95 26.82 122.89 245.99 374.08 328.61 (372.19) (287.95)
Shareholders Equity (Total)
126.95 26.82 122.89 245.99 374.08 328.61 37.26 —
Shareholders Equity and Liabilities (Total)
264.50 275.80 313.80 400.12 463.46 403.83 88.37 —
Shares (Common)
18.17 3.53 3.36 3.23 3.15 2.85 0.06 —
Shares (Preferred)
— — — — — — 0.01 —
Shareholders Equity (Tangible)
126.95 26.82 122.89 245.99 374.08 328.61 37.26 —
Net Debt
(72.71) 38.69 (73.21) (191.17) (309.73) (285.20) (41.02) (113.91)
Total Debt
96.24 197.38 130.11 96.34 29.76 29.67 29.06 28.87

Fold the line items

In millions of $ except per-share values · columns are period end dates